Trial Profile
A safety and efficacy study of lacosamide in patients with refractory focal epilepsy with seizure clustering
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2016 New trial record